City Therapeutics Inc.
CTY | NASDAQ
$20.88
+$0.17 (+0.82%)
At close: Nov 2, 2026, 4:00 PM ET
Fiscal Quarter Period Ending | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 | Q4 2019 Dec 31, 2019 | Q3 2019 Sep 30, 2019 | Q2 2019 Jun 30, 2019 | Q1 2019 Mar 31, 2019 | Q4 2018 Dec 31, 2018 | Q3 2018 Sep 30, 2018 | Q2 2018 Jun 30, 2018 | Q1 2018 Mar 31, 2018 | Q4 2017 Dec 31, 2017 | Q3 2017 Sep 30, 2017 | Q2 2017 Jun 30, 2017 | Q1 2017 Mar 31, 2017 | Q4 2016 Dec 31, 2016 | Q3 2016 Sep 30, 2016 | Q2 2016 Jun 30, 2016 | Q1 2016 Mar 31, 2016 | Q4 2015 Dec 31, 2015 | Q3 2015 Sep 30, 2015 | Q2 2015 Jun 30, 2015 | Q1 2015 Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 430M | 503M | 386M | 477M | 477M | 487M | 405M | 453M | 427M | 380M | 846M | 265M | 268M | 278M | 238M | 255M | 288M | 304M | 321M | 268M | 238M | 247M |
Depreciation & Amortization | 327M | 328M | 347M | 344M | 337M | 336M | 356M | 360M | 361M | 360M | 400M | 397M | 395M | 389M | 420M | 423M | 421M | 415M | 462M | 462M | 459M | 456M |
Stock-Based Compensation | n/a | n/a | 26M | n/a | n/a | n/a | 24M | n/a | n/a | n/a | 27M | n/a | n/a | n/a | 22M | n/a | n/a | n/a | 21M | n/a | n/a | n/a |
Other Working Capital | -1.35B | -882M | -923M | 25M | 207M | -220M | -426M | -587M | 402M | -177M | -427M | -540M | -574M | -979M | -1.09B | -920M | -1.01B | -505M | -820M | -532M | 48M | -243M |
Other Non-Cash Items | 404M | -98M | 1.4B | -108M | -250M | -330M | 232M | 1.09B | -288M | -322M | -1.45B | -129M | -505M | -186M | 61M | -54M | 311M | -305M | 88M | 325M | -299M | -241M |
Deferred Income Tax | 8M | 11M | -196M | 31M | 32M | 33M | -39M | -13M | -37M | 41M | 680M | 30M | 31M | 32M | 71M | 17M | 17M | 18M | -53M | 62M | 87M | 93M |
Change in Working Capital | -470M | 41M | -948M | 68M | 177M | 206M | 161M | -989M | 579M | 250M | 113M | 34M | 405M | 111M | -170M | 85M | -500M | 315M | -288M | -331M | 42M | 172M |
Operating Cash Flow | 699M | 785M | 1.02B | 812M | 773M | 732M | 1.14B | 901M | 1.04B | 709M | 620M | 597M | 594M | 624M | 642M | 726M | 537M | 747M | 551M | 786M | 527M | 727M |
Capital Expenditures | -289M | -317M | -278M | -260M | -229M | -288M | -308M | -222M | -218M | -292M | -242M | -392M | -376M | -318M | -399M | -314M | -275M | -271M | -348M | -335M | -304M | -260M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 214M | 1.15B | -236M | -152M | -193M | -87M | -478M | 1.01B | -540M | -108M | -169M | -5M | 108M | -42M | 104M | -156M | 375M | -398M | 598M | -188M | -123M | -260M |
Investing Cash Flow | -75M | 830M | -514M | -412M | -422M | -375M | -786M | 791M | -758M | -400M | -411M | -397M | -268M | -360M | -295M | -470M | 100M | -669M | 250M | -523M | -427M | -520M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 3M | -8M | 1M | 4M | 2M | -9M | 1M | 5M | -5M | -6M | 3M | 2M | 12M | -18M | 2M | -3M | n/a | -4M | 6M | -3M | n/a | -6M |
Dividend Paid | -425M | -500M | -500M | -400M | -350M | -350M | -350M | -350M | -275M | -300M | -200M | -200M | -350M | -250M | -350M | -250M | -400M | -300M | -400M | -650M | n/a | -300M |
Other Financial Acitivies | -202M | -1.11B | -2M | -4M | -3M | -3M | -4M | -1.35B | -4M | -4M | -12M | -2M | 12M | -1M | 1M | -3M | -237M | 223M | -407M | 390M | -100M | 93M |
Financial Cash Flow | -627M | -1.61B | -502M | -404M | -353M | -353M | -354M | -1.7B | -279M | -304M | -212M | -202M | -338M | -251M | -349M | -253M | -637M | -77M | -807M | -260M | -100M | -207M |
Net Cash Flow | -3M | 4M | -1M | -4M | 3M | 4M | n/a | -5M | 5M | 5M | -3M | -2M | -12M | 13M | -2M | 3M | n/a | 1M | -6M | 3M | n/a | n/a |
Free Cash Flow | 410M | 468M | 737M | 552M | 544M | 444M | 831M | 679M | 824M | 417M | 378M | 205M | 218M | 306M | 243M | 412M | 262M | 476M | 203M | 451M | 223M | 467M |
Adj. Free Cash Flow | 410M | 468M | 711M | 552M | 544M | 444M | 807M | 679M | 824M | 417M | 351M | 205M | 218M | 306M | 221M | 412M | 262M | 476M | 182M | 451M | 223M | 467M |
Maintenance CapEx | -289M | -317M | -278M | -260M | -229M | -288M | -308M | -215.13M | -218M | -292M | -242M | -392M | -376M | -318M | -399M | -314M | -274.29M | -245.32M | -339.59M | -285.12M | -295.03M | -256.64M |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -713.41K | -25.68M | -8.41M | -49.88M | -8.97M | -3.36M |
Owner Earnings | 410M | 468M | 737M | 552M | 544M | 444M | 831M | 685.87M | 824M | 417M | 378M | 205M | 218M | 306M | 243M | 412M | 262.71M | 501.68M | 211.41M | 500.88M | 231.97M | 470.36M |
Add to Watchlist
Select watchlists to add or remove CTY